- Home
- LAB vs PACB Comparison
LAB vs PACB Comparison
Compare LAB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- PACB
- Stock Information
- Founded
- LAB 1999
- PACB 2000
- Country
- LAB United States
- PACB United States
- Employees
- LAB N/A
- PACB N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- LAB Industrials
- PACB Industrials
- Exchange
- LAB Nasdaq
- PACB Nasdaq
- Market Cap
- LAB 473.2M
- PACB 381.5M
- IPO Year
- LAB 2011
- PACB 2010
- Fundamental
- Price
- LAB $1.35
- PACB $1.23
- Analyst Decision
- LAB Buy
- PACB Buy
- Analyst Count
- LAB 2
- PACB 7
- Target Price
- LAB $2.50
- PACB $1.90
- AVG Volume (30 Days)
- LAB 1.1M
- PACB 5.1M
- Earning Date
- LAB 10-29-2025
- PACB 11-06-2025
- Dividend Yield
- LAB N/A
- PACB N/A
- EPS Growth
- LAB N/A
- PACB N/A
- EPS
- LAB N/A
- PACB N/A
- Revenue
- LAB $172,271,000.00
- PACB $156,110,000.00
- Revenue This Year
- LAB N/A
- PACB $6.15
- Revenue Next Year
- LAB N/A
- PACB $15.68
- P/E Ratio
- LAB N/A
- PACB N/A
- Revenue Growth
- LAB 76.33
- PACB N/A
- 52 Week Low
- LAB $0.92
- PACB $0.85
- 52 Week High
- LAB $2.32
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- LAB 55.30
- PACB 45.49
- Support Level
- LAB $1.27
- PACB $1.15
- Resistance Level
- LAB $1.41
- PACB $1.32
- Average True Range (ATR)
- LAB 0.08
- PACB 0.07
- MACD
- LAB 0.01
- PACB -0.00
- Stochastic Oscillator
- LAB 68.18
- PACB 40.00
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.